Antibodies for the treatment of bacterial infections: current experience and future prospects
Christopher Bebbington(Curtin University), Geoffrey Yarranton
Cited by 96
Related Papers
Chimeric Receptors Providing Both Primary and Costimulatory Signaling in T Cells from a Single Gene Product
|The Journal of Immunology|1998|546
Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa
|Critical Care Medicine|2012|182
GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia
|Blood|2013|155
An Engineered Human Antibody Fab Fragment Specific for <i>Pseudomonas aeruginosa</i> PcrV Antigen Has Potent Antibacterial Activity
|Infection and Immunity|2008|122
AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice
|International Archives of Allergy and Immunology|2019|111